Methamphetamine-Associated Cardiomyopathy Versus Other Non-Ischaemic Cardiomyopathies: A Case-Controlled Study

Catheter Ablation of Ventricular Arrhythmia in Non-Ischaemic Cardiomyopathy: Anteroseptal versus Inferolateral Scar Sub-Types

Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

BACKGROUND Crystal methamphetamine has become a drug of widespread use. Previous reports describe myocardial infarction, pulmonary edema, and aortic dissection related to methamphetamine use. Cardiomyopathy due to methamphetamine exposure has been rarely described. METHODS We identified 1640 patients admitted in a 4-yr period with a primary or secondary diagnosis of cardiomyopathy. We exclude...

a study on construction of iranian life tables: the case study of modified brass logit system

چکیده ندارد.

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance

Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 mo...

Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies

Cardiovascular Magnetic Resonance (CMR) is recognised as a valuable clinical tool which in a single scan setting can assess ventricular volumes and function, myocardial fibrosis, iron loading, flow quantification, tissue characterisation and myocardial perfusion imaging. The advent of CMR using extrinsic and intrinsic contrast-enhanced protocols for tissue characterisation have dramatically cha...